Article Details
Retrieved on: 2023-11-16 16:02:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca's Imfinzi plus chemoradiotherapy fail main goal of late stage trial. November 13, 2023. A company logo is seen at the AstraZeneca site ...
Article found on: www.reuters.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here